NCT07110233View on ClinicalTrials.gov

Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma

NANot yet recruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Hepatocellular CarcinomaUnresectable Hepatocellular CarcinomaHepatocellular CancerHepatocellular Carcinoma Non-resectable
Interventions
DEVICE

TheraSphere® Yttrium-90 microspheres

Administered intra-arterially

OTHER

Health Related Quality of Life Questionnaires (HRQOL)

Surveys administered

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER